Charles River Laboratories (CRL)
Cash conversion cycle
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | 101.16 | 78.78 | 77.00 | 74.36 | 112.87 | 125.16 | 128.92 | 105.78 | 95.73 | 87.56 | 96.92 | 102.44 | 102.25 | 102.13 | 95.11 | 92.59 | 93.59 | 96.42 | 86.67 | 86.37 |
Days of sales outstanding (DSO) | days | 69.52 | 67.45 | 67.90 | — | 66.88 | 74.93 | 74.84 | 71.55 | 68.61 | 72.32 | 74.09 | 76.04 | 78.84 | 75.65 | 72.05 | 74.12 | 72.28 | 76.33 | 82.51 | 77.24 |
Number of days of payables | days | 44.94 | 36.66 | 37.84 | 33.98 | 90.86 | 86.92 | 106.13 | 108.07 | 95.24 | 61.64 | 55.32 | 67.28 | 67.44 | 54.49 | 46.87 | 58.36 | 64.95 | 66.48 | 63.84 | 52.26 |
Cash conversion cycle | days | 125.74 | 109.57 | 107.06 | 40.38 | 88.89 | 113.17 | 97.63 | 69.25 | 69.10 | 98.24 | 115.69 | 111.20 | 113.65 | 123.30 | 120.29 | 108.35 | 100.92 | 106.27 | 105.34 | 111.35 |
December 31, 2023 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 101.16 + 69.52 – 44.94
= 125.74
The cash conversion cycle is a measure of how quickly a company can convert its investments in inventory into cash flows from sales. A shorter cash conversion cycle indicates more efficient operations and better liquidity management.
Analyzing the cash conversion cycle of Charles River Laboratories over the past few quarters, it is evident that there have been fluctuations in the efficiency of the company's working capital management.
In the most recent quarter, ending on December 31, 2023, the cash conversion cycle increased significantly to 125.74 days. This was driven by a notable increase in the number of days it took the company to convert inventory into sales and eventually into cash. This suggests a potential slowdown in sales or challenges in managing inventory turnover efficiently during this period.
Conversely, in the first quarter of 2023, the cash conversion cycle was notably lower at 40.38 days, indicating a more efficient working capital cycle. It is worth noting that this rapid conversion of investments into cash highlights effective inventory management and faster sales collection.
Overall, monitoring the trend of the cash conversion cycle is crucial for assessing Charles River Laboratories' operational efficiency and cash flow management. A decreasing trend over time would be desirable, indicating improved working capital management and potentially leading to enhanced financial performance and liquidity in the long term.
Peer comparison
Dec 31, 2023